Zedonac-MR Novo Tablet is a combination medication containing Chlorzoxazone 250 mg, Diclofenac 50 mg, and Paracetamol 325 mg, formulated to provide effective relief from musculoskeletal pain and inflammation. Chlorzoxazone acts as a centrally acting muscle relaxant, alleviating muscle spasms and stiffness by depressing the central nervous system. Diclofenac, a nonsteroidal anti-inflammatory drug (NSAID), exerts potent anti-inflammatory, analgesic, and antipyretic effects by inhibiting cyclooxygenase enzymes, thereby reducing prostaglandin synthesis. Paracetamol contributes additional analgesic and antipyretic benefits through central inhibition of prostaglandin synthesis, enhancing overall pain relief. This combination is particularly useful in managing conditions such as acute musculoskeletal injuries, strains, sprains, and inflammatory disorders where muscle spasm and pain coexist. Zedonac-MR Novo Tablet should be used under medical supervision, considering contraindications such as hypersensitivity to any component, peptic ulcer disease, hepatic or renal impairment, and caution in patients with cardiovascular risks. Common adverse effects may include gastrointestinal discomfort, dizziness, or allergic reactions. It is advisable to adhere to prescribed dosages and duration to minimize potential risks. This combination therapy offers a synergistic approach to pain management, improving patient comfort and mobility.